Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Other Non Operating Income (2022 - 2025)

Historic Other Non Operating Income for CervoMed (CRVO) over the last 9 years, with Q3 2025 value amounting to -$1227.0.

  • CervoMed's Other Non Operating Income rose 6433.14% to -$1227.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$8892.0, marking a year-over-year decrease of 10597.64%. This contributed to the annual value of -$991.0 for FY2024, which is 10001.83% down from last year.
  • Per CervoMed's latest filing, its Other Non Operating Income stood at -$1227.0 for Q3 2025, which was up 6433.14% from -$10256.0 recorded in Q2 2025.
  • Over the past 5 years, CervoMed's Other Non Operating Income peaked at $4.8 million during Q3 2023, and registered a low of -$620059.0 during Q4 2022.
  • For the 4-year period, CervoMed's Other Non Operating Income averaged around $368372.0, with its median value being -$247.0 (2024).
  • Per our database at Business Quant, CervoMed's Other Non Operating Income surged by 542944545.45% in 2023 and then plummeted by 405222.67% in 2025.
  • CervoMed's Other Non Operating Income (Quarter) stood at -$620059.0 in 2022, then surged by 99.9% to -$600.0 in 2023, then surged by 554.33% to $2726.0 in 2024, then crashed by 145.01% to -$1227.0 in 2025.
  • Its last three reported values are -$1227.0 in Q3 2025, -$10256.0 for Q2 2025, and -$135.0 during Q1 2025.